Harvard Bioscience, Inc.HBIONASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

4 analysts·Low coverage

100%

Rating Distribution

Strong Buy

00%

Buy

4100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 1300% higher.

Bear Case

$7.00

+1300%

Consensus

$7.00

+1300%

Bull Case

$7.00

+1300%

Price Range4 analysts

Low

Consensus

High

$7.00

Current Target

Current Price

$0.50

Upside to Target

$6.50

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.10(1 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+4.21%

EPS+110.53%

Earnings Surprises

Beat rate:42%(5/12 quarters)

Avg surprise:-32.3%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Aug 8, 2024KeyBanc

KeyBanc Reiterates Overweight Rating on Harvard Bioscience Inc. (HBIO)

Target:$7.00

+124.4%from $3.12

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance